2014-2024年全球慢性阻塞性肺疾病微生态学文献计量分析

doi:10.3969/j.issn.1004-583X.2024.11.008

摘要/Abstract

摘要：

目的分析全球慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)微生态学英文文献的研究热点和前沿趋势。方法利用Web of Science核心合集数据库,检索2014-2024年有关COPD微生态学的文献。使用VOSviewer 和Citespace工具,对该研究领域的国家、机构、作者、参考文献和关键词进行合著、共被引和共现分析,并进行可视化呈现。结果共纳入1 492篇文献,总体发文量逐年递增。美国在该领域的发文量最多。Dave Singh是发文量最高的作者,Sanjay Sethi则是被引频次最高的作者。Int J Chron Obstruct Pulmon Dis是该领域的重要学术出版物。参考文献和关键词分析表明,肺微生物组和肠道微生物组是未来研究的主要热点领域。结论 COPD微生态学研究蓬勃发展。我国应加强与国际的交流与合作,进一步关注前沿性的临床研究,并探索先进的实验室技术。

关键词: 肺疾病, 慢性阻塞性, 文献计量学分析, 微生态学, VOSviewer, Citespace

Abstract:

Objective To analyze the global research hotspots and emerging trends in English-language literatures reporting microecology of chronic obstructive pulmonary disease (COPD). Methods Articles reporting microecology of COPD from 2014 to 2024 were searched in the Web of Science Core Collection database. VOSviewer and Citespace tools were employed for co-authorship, co-citation, and co-occurrence analyses of countries, institutions, authors, references, and keywords, which were finally visualized. Results A total of 1, 492 articles were included in the analysis. Overall, there was an annual increase in the publication volume, with the United States leading in the publication output. Dave Singh was identified as the most productive author, while Sanjay Sethi had the highest citation frequency. Int J Chron Obstruct Pulmon Dis was noted as a significant academic publication in this field. Based on the analysis of references and keywords, the lung microbiome and gut microbiome were identified as major research hotspots in the future. Conclusion Microecology research in COPD is flourishing. It is essential for Chinese investigators to enhance international exchanges and cooperation, focusing on prospective clinical studies and the exploration of advanced laboratory techniques.

Key words: pulmonary disease, chronic obstructive, bibliometric analysis, microecology, VOSviewer, Citespace

中图分类号:

R563.9

朱玲珑, 黄微娜. 2014-2024年全球慢性阻塞性肺疾病微生态学文献计量分析[J]. 临床荟萃, 2024, 39(11): 1007-1015.

Zhu Linglong, Huang Weina. Global research on the microecology in chronic obstructive pulmonary disease from 2014 to 2024: A bibliometric analysis[J]. Clinical Focus, 2024, 39(11): 1007-1015.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2024.11.008

https://huicui.hebmu.edu.cn/CN/Y2024/V39/I11/1007

图/表 7

参考文献 21

[1]	Boers E, Barrett M, Su JG, et al. Global burden of chronic obstructive pulmonary disease through 2050[J]. JAMA Netw Open, 2023, 6(12):e2346598.
[2]	Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: A systematic analysis for the global burden of disease study 2017[J]. Lancet, 2019, 394(10204):1145-1158. doi: S0140-6736(19)30427-1 pmid: 31248666
[3]	GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet Respir Med, 2020, 8(6):585-596. doi: 10.1016/S2213-2600(20)30105-3 pmid: 32526187
[4]	Adeloye D, Song P, Zhu Y, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: A systematic review and modelling analysis[J]. Lancet Respir Med, 2022, 10(5):447-458. doi: 10.1016/S2213-2600(21)00511-7 pmid: 35279265
[5]	Chen S, Kuhn M, Prettner K, et al. The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: A health-augmented macroeconomic modelling study[J]. Lancet Glob Health, 2023, 11(8):e1183-e1193.
[6]	Tsay JJ, Segal LN. Could the sputum microbiota be a biomarker that predicts mortality after acute exacerbations of chronic obstructive pulmonary disease?[J]. Am J Respir Crit Care Med, 2019, 199(10):1175-1176.
[7]	Russo C, Colaianni V, Ielo G, et al. Impact of lung microbiota on COPD[J]. Biomedicines, 2022, 10(6):1337.
[8]	Martin R, Nora M, Anna L, et al. Altered hypoxia-induced cellular responses and inflammatory profile in lung fibroblasts from COPD patients compared to control subjects[J]. Respir Res, 2024, 25(1):282.
[9]	郑成玲, 蒋慧生, 王金鹏. 老年COPD合并肺部感染患者血清免疫状态变化吸预后价值[J]. 疑难病杂志, 2023, 22(12):1268-1272+1284.
[10]	van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping[J]. Scientometrics, 2010, 84(2):523-538. pmid: 20585380
[11]	Arruda H, Silva ER, Lessa M, et al. VOSviewer and bibliometrix[J]. J Med Libr Assoc, 2022, 110(3):392-395. doi: 10.5195/jmla.2022.1434 pmid: 36589296
[12]	Synnestvedt MB, Chen C, Holmes JH. CiteSpace II: Visualization and knowledge discovery in bibliographic databases[J]. AMIA Annu Symp Proc, 2005, 2005:724-728.
[13]	Chen C, Dubin R, Kim MC. Emerging trends and new developments in regenerative medicine: Ascientometric update (2000-2014)[J]. Expert Opin Biol Ther, 2014, 14(9):1295-1317.
[14]	Chen C. Searching for intellectual turning points: Progressive knowledge domain visualization[J]. Proc Natl Acad Sci U S A, 2004, 101 Suppl 1(Suppl 1):5303-5310.
[15]	Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China[J]. Allergy, 2020, 75(7):1730-1741.
[16]	Roy MG, Livraghi-Butrico A, Fletcher AA, et al. Muc5b is required for airway defence[J]. Nature, 2014, 505(7483):412-416.
[17]	Dickson RP, Martinez FJ, Huffnagle GB. The role of the microbiome in exacerbations of chronic lung diseases[J]. Lancet, 2014, 384(9944):691-702. doi: 10.1016/S0140-6736(14)61136-3 pmid: 25152271
[18]	Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease[J]. N Engl J Med, 2008, 359(22):2355-2365.
[19]	Sethi S, Evans N, Grant BJ, et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease[J]. N Engl J Med, 2002, 347(7):465-471.
[20]	Erb-Downward JR, Thompson DL, Han MK, et al. Analysis of the lung microbiome in the “healthy” smoker and in COPD[J]. PLoS One, 2011, 6(2):e16384.
[21]	Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary[J]. Am J Respir Crit Care Med, 2013, 187(4):347-365.

排名	期刊	国家	文章数量	IF(2022年)	JCR类别(2022年)	H指数	总引用次数
1	Int J Chron Obstruct Pulmon Dis	新西兰	102	2.8	Q2	25	1 936
2	Respir Res	英国	62	5.8	Q1	26	1 552
3	PLoS One	美国	58	3.7	Q1	26	1 830
4	Sci Rep	英国	32	4.6	Q1	17	671
5	Front Microbiol	瑞士	25	5.2	Q2	8	213
6	Front Immunol	瑞士	25	7.3	Q1	13	516
7	Am J Respir Crit Care Med	美国	23	24.7	Q1	18	1 359
8	BMC Pulm Med	英国	23	3.1	Q2	11	307
9	Thorax	英国	22	10.0	Q1	17	1 432
10	Eur Respir J	英国	22	24.9	Q1	19	1 493
11	Int J Mol Sci	瑞士	22	5.6	Q2	8	336

排名	期刊	国家	文章数量	IF(2022年)	JCR类别(2022年)	H指数	总引用次数
1	Int J Chron Obstruct Pulmon Dis	新西兰	102	2.8	Q2	25	1 936
2	Respir Res	英国	62	5.8	Q1	26	1 552
3	PLoS One	美国	58	3.7	Q1	26	1 830
4	Sci Rep	英国	32	4.6	Q1	17	671
5	Front Microbiol	瑞士	25	5.2	Q2	8	213
6	Front Immunol	瑞士	25	7.3	Q1	13	516
7	Am J Respir Crit Care Med	美国	23	24.7	Q1	18	1 359
8	BMC Pulm Med	英国	23	3.1	Q2	11	307
9	Thorax	英国	22	10.0	Q1	17	1 432
10	Eur Respir J	英国	22	24.9	Q1	19	1 493
11	Int J Mol Sci	瑞士	22	5.6	Q2	8	336

题目	期刊	第一作者	发表年份 (年)	被引次数
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China	Allergy	Zhang JJ	2020	1 984
Muc5b is required for airway defence	Nature	Roy MG	2014	522
The role of the microbiome in exacerbations of chronic lung diseases	Lancet	Dickson RP	2014	303
Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model	PLoS One	Sussan TE	2015	283
Lung microbiome dynamics in COPD exacerbations	Eur Respir J	Wang Z	2016	247
Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease	J Clin Microbiol	Huang YJ	2014	221
Clinical phenotypes in adult patients with bronchiectasis	Eur Respir J	Aliberti S	2016	190
2019 novel coronavirus (2019-nCoV) outbreak: A new challenge	J Glob Antimicrob Resist	Lupia T	2020	189
Airway microbiota is associated with upregulation of the PI3K pathway in lung cancer	Am J Respir Crit Care Med	Tsay JJ	2018	186
Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations	Thorax	Mayhew D	2018	176

题目	期刊	第一作者	发表年份 (年)	被引次数
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China	Allergy	Zhang JJ	2020	1 984
Muc5b is required for airway defence	Nature	Roy MG	2014	522
The role of the microbiome in exacerbations of chronic lung diseases	Lancet	Dickson RP	2014	303
Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model	PLoS One	Sussan TE	2015	283
Lung microbiome dynamics in COPD exacerbations	Eur Respir J	Wang Z	2016	247
Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease	J Clin Microbiol	Huang YJ	2014	221
Clinical phenotypes in adult patients with bronchiectasis	Eur Respir J	Aliberti S	2016	190
2019 novel coronavirus (2019-nCoV) outbreak: A new challenge	J Glob Antimicrob Resist	Lupia T	2020	189
Airway microbiota is associated with upregulation of the PI3K pathway in lung cancer	Am J Respir Crit Care Med	Tsay JJ	2018	186
Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations	Thorax	Mayhew D	2018	176